Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Touyun Biotech GroupHKSE:01332 +0.60%22 PE Ratio (TTM) is 16.80 as of Aug. 30, 2026, which is 38% above its 10-year median of 12.20. GuruFocus rates HKSE:01332 with a GF Score™ of 22/100 and a GF Value™ of HK$0.16 (Fairly Valued). The stock has 6 warning signs investors should review. Among 316 Packaging & Containers companies, Touyun Biotech Group ranks worse than 51.9% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-30), Touyun Biotech Group's share price is
HK$0.168.
Touyun Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.01. Therefore, Touyun Biotech Group's PE Ratio (TTM) for today is 16.80.
The historical rank and industry rank for Touyun Biotech Group's PE Ratio (TTM) or its related term are showing as below:
HKSE:01332'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 4.16 Med: 12.2 Max: 28.5
Current: 16.8
During the past 13 years, the highest PE Ratio (TTM) of Touyun Biotech Group was 28.50. The lowest was 4.16. And the median was 12.20.
HKSE:01332's PE Ratio (TTM) is ranked worse than 51.9% of 316
companies
in the Packaging & Containers industry
Industry Median: 16.235
vs HKSE:01332: 16.80
Touyun Biotech Group's EPS (Basic) for the
six
months ended in Dec. 2025 was HK$0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.01.
Touyun Biotech Group (HKSE:01332) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Touyun Biotech Group PE Ratio (TTM) Related Terms
Touyun Biotech Group PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01332 vs SW, PKG, IP: PE Ratio (TTM) Comparison
For the Packaging & Containers subindustry, Touyun Biotech Group's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group PE Ratio (TTM) vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Touyun Biotech Group's Share Price of today is HK$0.168.
For company reported semi-annually, Touyun Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Touyun Biotech Group (HKSE:01332) has a PE Ratio (TTM) of 16.80 as of Aug. 30, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Touyun Biotech Group and its competitors. This is 38% above median its historical median of 12.20. Over the past decade, Touyun Biotech Group's PE Ratio (TTM) has ranged from 4.16 to 28.50. According to the industry distribution chart, Touyun Biotech Group ranks #164 out of 316 companies in the Packaging & Containers industry, placing it in the top 51.9%.
Is Touyun Biotech Group's PE Ratio (TTM) too high?
Touyun Biotech Group's current PE Ratio (TTM) of 16.80 is 38% above median its 10-year median of 12.20. Over the past 10 years, this metric has ranged from a low of 4.16 to a high of 28.50. The Packaging & Containers industry median PE Ratio (TTM) is 16.24. Touyun Biotech Group's value of 16.80 is 3.5% above this industry median. Based on the distribution chart, Touyun Biotech Group ranks #164 out of 316 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Touyun Biotech Group has a GF Score™ of 22/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's PE Ratio (TTM) compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #164 out of 316 companies for PE Ratio (TTM). This places Touyun Biotech Group in the lower half of its industry. The industry median PE Ratio (TTM) is 16.24. Touyun Biotech Group's value of 16.80 is 3.5% above this benchmark. Historically, Touyun Biotech Group's own PE Ratio (TTM) has ranged from 4.16 to 28.50 over the past decade. While the company's 10-year median is 12.20 vs. the industry median of 16.24, Touyun Biotech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Packaging & Containers company?
The median PE Ratio (TTM) among Packaging & Containers companies is 16.24, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touyun Biotech Group's current PE Ratio (TTM) of 16.80 is 3.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median PE Ratio (TTM) is 16.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current PE Ratio (TTM) is 16.80, which is 38% above median its own 10-year median of 12.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.17 — trading 5% above its estimated fair value. The current PE Ratio (TTM) is 16.80, which is 38% above median its 10-year median of 12.20 and 3.5% above the Packaging & Containers industry median of 16.24. Touyun Biotech Group's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current PE Ratio (TTM) is 16.80 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be overvalued.
The current stock price of HK$0.17 is trading 5% above its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Fairly Valued.
Key valuation signals for HKSE:01332:
PE Ratio (TTM): 16.80 (38% above median its 10-year median of 12.20)
GF Value™: HK$0.16 vs. price of HK$0.17 (5% above fair value)
Industry Position: 3.5% above the Packaging & Containers median (#164 of 316)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
22GF Score
Get the complete analysis for HKSE:01332
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
